Literature DB >> 2117257

Negative regulation of human c-fos expression by the retinoblastoma gene product.

P D Robbins1, J M Horowitz, R C Mulligan.   

Abstract

Inactivation of the retinoblastoma susceptibility gene (RB-1) has been associated with the aetiology of many types of human cancers, leading to the classification of RB-1 as an anti-oncogene or tumour suppressor gene. Given that the protein product of RB-1 (Rb) has a nuclear localization and DNA-binding activity in vitro, it is possible that Rb regulates transcription of certain genes. The promoter of the c-fos gene might be a target for regulation by Rb, because both v-fos and RB-1 are associated with the induction of osteosarcomas in mice and humans, respectively. Also, fos expression is thought to be required for quiescent cells to enter the cell cycle, making the fos promoter an attractive target for suppressors of cell growth. Here we report that Rb can repress c-fos expression and AP-1 transcriptional activity in both serum-induced and cycling 3T3 cells. We have mapped a cis-acting element in the human c-fos promoter that can confer repression by Rb to a heterologous promoter. We have the termed the cis-acting sequence regulated by Rb the retinoblastoma control element.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117257     DOI: 10.1038/346668a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  72 in total

1.  Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.

Authors:  S B Kennett; A J Udvadia; J M Horowitz
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

2.  Expression of the murine RanBP1 and Htf9-c genes is regulated from a shared bidirectional promoter during cell cycle progression.

Authors:  G Guarguaglini; A Battistoni; C Pittoggi; G Di Matteo; B Di Fiore; P Lavia
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.

Authors:  A Ray; K S LaForge; P B Sehgal
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 4.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

5.  Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.

Authors:  P A Hamel; R M Gill; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

6.  Expression profiling of p53-target genes in copper-mediated neuronal apoptosis.

Authors:  Jacob W Vanlandingham; Nadine M Tassabehji; Rikki C Somers; Cathy W Levenson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

7.  Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.

Authors:  S W Hiebert
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Age-dependent alterations of c-fos and growth regulation in human fibroblasts expressing the HPV16 E6 protein.

Authors:  Y Yan; M M Ouellette; J W Shay; W E Wright
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

9.  CREB represses transcription of fos promoter: role of phosphorylation.

Authors:  R Ofir; V J Dwarki; D Rashid; I M Verma
Journal:  Gene Expr       Date:  1991-04

10.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization.

Authors:  S W Lee; C Tomasetto; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.